- Home
- Publications
- Publication Search
- Publication Details
Title
Exploiting DNA repair defects in colorectal cancer
Authors
Keywords
-
Journal
Molecular Oncology
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-02-04
DOI
10.1002/1878-0261.12467
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inherited DNA-Repair Defects in Colorectal Cancer
- (2018) Saud H. AlDubayan et al. AMERICAN JOURNAL OF HUMAN GENETICS
- European cancer mortality predictions for the year 2018 with focus on colorectal cancer
- (2018) M Malvezzi et al. ANNALS OF ONCOLOGY
- A phase 1 dose-escalation study of veliparib with bimonthly FOLFIRI in patients with advanced solid tumours
- (2018) Jordan Berlin et al. BRITISH JOURNAL OF CANCER
- A phase 2 study of the PARP inhibitor veliparib plus temozolomide in patients with heavily pretreated metastatic colorectal cancer
- (2018) Michael J. Pishvaian et al. CANCER
- Mutations of key driver genes in colorectal cancer progression and metastasis
- (2018) Dongdong Huang et al. CANCER AND METASTASIS REVIEWS
- Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality
- (2018) Ewa Gogola et al. CANCER CELL
- Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer
- (2018) Rona Yaeger et al. CANCER CELL
- The identification of the ATR inhibitor VE-822 as a therapeutic strategy for enhancing cisplatin chemosensitivity in esophageal squamous cell carcinoma
- (2018) Qi Shi et al. CANCER LETTERS
- Crosstalk of DNA double-strand break repair pathways in poly(ADP-ribose) polymerase inhibitor treatment of breast cancer susceptibility gene 1/2-mutated cancer
- (2018) Shigeaki Sunada et al. CANCER SCIENCE
- An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
- (2018) Jianfang Liu et al. CELL
- Main steps in DNA double-strand break repair: an introduction to homologous recombination and related processes
- (2018) Lepakshi Ranjha et al. CHROMOSOMA
- Evaluation of Prexasertib, a Checkpoint Kinase 1 Inhibitor, in a Phase Ib Study of Patients with Squamous Cell Carcinoma
- (2018) David S. Hong et al. CLINICAL CANCER RESEARCH
- Update on Hereditary Colorectal Cancer: Improving the Clinical Utility of Multigene Panel Testing
- (2018) Marie Lorans et al. Clinical Colorectal Cancer
- Parp Inhibitors for the Treatment of Ovarian Cancer
- (2018) Laura Cortesi et al. CURRENT CANCER DRUG TARGETS
- Nivolumab in the treatment of microsatellite instability high metastatic colorectal cancer
- (2018) Amir Mehrvarz Sarshekeh et al. Future Oncology
- Mutation analysis of adenomas and carcinomas of the colon: Early and late drivers
- (2018) Roger K. Wolff et al. GENES CHROMOSOMES & CANCER
- Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
- (2018) Michael J. Overman et al. JOURNAL OF CLINICAL ONCOLOGY
- Prexasertib, a cell cycle checkpoint kinase 1 and 2 inhibitor, in BRCA wild-type recurrent high-grade serous ovarian cancer: a first-in-class proof-of-concept phase 2 study
- (2018) Jung-Min Lee et al. LANCET ONCOLOGY
- Loss of E2F7 confers resistance to poly-ADP-ribose polymerase (PARP) inhibitors in BRCA2-deficient cells
- (2018) Kristen E Clements et al. NUCLEIC ACIDS RESEARCH
- PARP Inhibitors in Ovarian Cancer
- (2018) Gloria Mittica et al. Recent Patents on Anti-Cancer Drug Discovery
- Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas
- (2018) Theo A. Knijnenburg et al. Cell Reports
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Restored replication fork stabilization, a mechanism of PARP inhibitor resistance, can be overcome by cell cycle checkpoint inhibition
- (2018) Brittany Haynes et al. CANCER TREATMENT REVIEWS
- Mechanisms of PARP inhibitor sensitivity and resistance
- (2018) Alan D. D’Andrea DNA REPAIR
- ATR kinase inhibitor AZD6738 potentiates CD8+ T cell–dependent antitumor activity following radiation
- (2018) Frank P. Vendetti et al. JOURNAL OF CLINICAL INVESTIGATION
- High speed of fork progression induces DNA replication stress and genomic instability
- (2018) Apolinar Maya-Mendoza et al. NATURE
- 53BP1 cooperation with the REV7–shieldin complex underpins DNA structure-specific NHEJ
- (2018) Hind Ghezraoui et al. NATURE
- Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma
- (2018) Olga Kondrashova et al. Nature Communications
- Prediction of DNA Repair Inhibitor Response in Short Term Patient-Derived Ovarian Cancer Organoids
- (2018) Sarah J. Hill et al. Cancer Discovery
- BRCA1 Mutation-Specific Responses to 53BP1 Loss-Induced Homologous Recombination and PARP Inhibitor Resistance
- (2018) Joseph Nacson et al. Cell Reports
- A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancer
- (2018) Vera Gorbunova et al. BRITISH JOURNAL OF CANCER
- Binding of platinum derivative, oxaliplatin to deoxyribonucleic acid: structural insight into antitumor action
- (2018) Bhumika Ray et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- The Clinical Impact of the Genomic Landscape of Mismatch Repair–Deficient Cancers
- (2018) Giovanni Germano et al. Cancer Discovery
- Genomic signatures as predictive biomarkers of homologous recombination deficiency in ovarian cancer
- (2017) Adriaan Vanderstichele et al. EUROPEAN JOURNAL OF CANCER
- ATR inhibition disrupts rewired homologous recombination and fork protection pathways in PARP inhibitor-resistant BRCA-deficient cancer cells
- (2017) Stephanie A. Yazinski et al. GENES & DEVELOPMENT
- CHK1-targeted therapy to deplete DNA replication-stressed, p53-deficient, hyperdiploid colorectal cancer stem cells
- (2017) Gwenola Manic et al. GUT
- Measurement of Telomere Length in Colorectal Cancers for Improved Molecular Diagnosis
- (2017) Eric Le Balc’h et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Genomic Rearrangement Signatures and Clinical Outcomes in High-Grade Serous Ovarian Cancer
- (2017) R Tyler Hillman et al. JNCI-Journal of the National Cancer Institute
- Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival
- (2017) Ahmedin Jemal et al. JNCI-Journal of the National Cancer Institute
- Combining Chk1/2 Inhibition with Cetuximab and Radiation Enhances In Vitro and In Vivo Cytotoxicity in Head and Neck Squamous Cell Carcinoma
- (2017) Ling Zeng et al. MOLECULAR CANCER THERAPEUTICS
- AZD6738, A Novel Oral Inhibitor of ATR, Induces Synthetic Lethality with ATM Deficiency in Gastric Cancer Cells
- (2017) Ahrum Min et al. MOLECULAR CANCER THERAPEUTICS
- Early genetic aberrations in patients with sporadic colorectal cancer
- (2017) Brooke R. Druliner et al. MOLECULAR CARCINOGENESIS
- Enhanced dependency of KRAS-mutant colorectal cancer cells on RAD51-dependent homologous recombination repair identified from genetic interactions in Saccharomyces cerevisiae
- (2017) Murugan Kalimutho et al. Molecular Oncology
- EZH2 promotes degradation of stalled replication forks by recruiting MUS81 through histone H3 trimethylation
- (2017) Beatrice Rondinelli et al. NATURE CELL BIOLOGY
- HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures
- (2017) Helen Davies et al. NATURE MEDICINE
- A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress
- (2017) Peter M Bruno et al. NATURE MEDICINE
- First FDA Approval Agnostic of Cancer Site — When a Biomarker Defines the Indication
- (2017) Steven Lemery et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- PARP inhibitors: Synthetic lethality in the clinic
- (2017) Christopher J. Lord et al. SCIENCE
- ATM-Deficient Colorectal Cancer Cells Are Sensitive to the PARP Inhibitor Olaparib
- (2017) Chen Wang et al. Translational Oncology
- DNA double-strand break repair pathway regulates PD-L1 expression in cancer cells
- (2017) Hiro Sato et al. Nature Communications
- A molecular portrait of microsatellite instability across multiple cancers
- (2017) Isidro Cortes-Ciriano et al. Nature Communications
- Secondary Somatic Mutations Restoring RAD51C and RAD51D Associated with Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma
- (2017) Olga Kondrashova et al. Cancer Discovery
- Analysis of Circulating Cell-Free DNA Identifies Multiclonal Heterogeneity of BRCA2 Reversion Mutations Associated with Resistance to PARP Inhibitors
- (2017) David Quigley et al. Cancer Discovery
- Prexasertib, a cell cycle checkpoint kinases 1 and 2 inhibitor, increases in vitro toxicity of PARP inhibition by preventing Rad51 foci formation in BRCA wild type high-grade serous ovarian cancer
- (2017) Ethan Brill et al. Oncotarget
- Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival
- (2017) Ahmedin Jemal et al. JNCI-Journal of the National Cancer Institute
- Genomic Rearrangement Signatures and Clinical Outcomes in High-Grade Serous Ovarian Cancer
- (2017) R Tyler Hillman et al. JNCI-Journal of the National Cancer Institute
- Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer
- (2017) Rachel Pearlman et al. JAMA Oncology
- Characterisation of PD-L1-positive subsets of microsatellite-unstable colorectal cancers
- (2016) Jung Ho Kim et al. BRITISH JOURNAL OF CANCER
- Replication fork stability confers chemoresistance in BRCA-deficient cells
- (2016) Arnab Ray Chaudhuri et al. NATURE
- Classification and characterization of microsatellite instability across 18 cancer types
- (2016) Ronald J Hause et al. NATURE MEDICINE
- The Fanconi anaemia pathway: new players and new functions
- (2016) Raphael Ceccaldi et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Cryo-EM structures of human RAD51 recombinase filaments during catalysis of DNA-strand exchange
- (2016) Jingfei Xu et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Phase II Study of Olaparib (AZD-2281) After Standard Systemic Therapies for Disseminated Colorectal Cancer
- (2016) L. Leichman et al. ONCOLOGIST
- DNA repair targeted therapy: The past or future of cancer treatment?
- (2016) Navnath S. Gavande et al. PHARMACOLOGY & THERAPEUTICS
- Functional crosstalk between DNA damage response proteins 53BP1 and BRCA1 regulates double strand break repair choice
- (2016) Ali Bakr et al. RADIOTHERAPY AND ONCOLOGY
- Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
- (2016) N. McGranahan et al. SCIENCE
- Efficiency of olaparib in colorectal cancer patients with an alteration of the homologous repair protein
- (2016) Francois Ghiringhelli et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Cryo-EM structures of human RAD51 recombinase filaments during catalysis of DNA-strand exchange
- (2016) Jingfei Xu et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- TAS-102, a novel antitumor agent: A review of the mechanism of action
- (2015) Heinz-Josef Lenz et al. CANCER TREATMENT REVIEWS
- A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant Cancer
- (2015) Felix Dietlein et al. CELL
- DNA Sequence Alignment by Microhomology Sampling during Homologous Recombination
- (2015) Zhi Qi et al. CELL
- FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of Chemotherapy
- (2015) G. Kim et al. CLINICAL CANCER RESEARCH
- LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent Mechanisms
- (2015) C. King et al. MOLECULAR CANCER THERAPEUTICS
- Chromosomal instability—mechanisms and consequences
- (2015) Shriram Venkatesan et al. MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
- REV7 counteracts DNA double-strand break resection and affects PARP inhibition
- (2015) Guotai Xu et al. NATURE
- First-line chemotherapy for mCRC—a review and evidence-based algorithm
- (2015) Chiara Cremolini et al. Nature Reviews Clinical Oncology
- TP53mutations, tetraploidy and homologous recombination repair defects in early stage high-grade serous ovarian cancer
- (2015) Jeremy Chien et al. NUCLEIC ACIDS RESEARCH
- Mismatch repair gene defects in sporadic colorectal cancer enhance immune surveillance
- (2015) Marco Scarpa et al. Oncotarget
- Low ATM protein expression and depletion of p53 correlates with olaparib sensitivity in gastric cancer cell lines
- (2014) Eiji Kubota et al. CELL CYCLE
- RPA-coated single-stranded DNA as a platform for post-translational modifications in the DNA damage response
- (2014) Alexandre Maréchal et al. CELL RESEARCH
- Triapine Disrupts CtIP-Mediated Homologous Recombination Repair and Sensitizes Ovarian Cancer Cells to PARP and Topoisomerase Inhibitors
- (2014) Z. Ping Lin et al. MOLECULAR CANCER RESEARCH
- 6-Thioguanine: A Drug With Unrealized Potential for Cancer Therapy
- (2014) Pashna N. Munshi et al. ONCOLOGIST
- Human Pol purified with accessory subunits is active in translesion DNA synthesis and complements Pol in cisplatin bypass
- (2014) Y.-S. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Visualization and quantification of nascent RAD51 filament formation at single-monomer resolution
- (2014) Andrea Candelli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- XRCC2 rs3218536 polymorphism decreases the sensitivity of colorectal cancer cells to poly(ADP-ribose) polymerase 1 inhibitor
- (2014) KAIWU XU et al. Oncology Letters
- The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints
- (2014) Nicolas J. Llosa et al. Cancer Discovery
- ATR Inhibition Broadly Sensitizes Ovarian Cancer Cells to Chemotherapy Independent of BRCA Status
- (2013) C. J. Huntoon et al. CANCER RESEARCH
- BRCA2 is epistatic to the RAD51 paralogs in response to DNA damage
- (2013) Ryan B. Jensen et al. DNA REPAIR
- Microsatellite instability induced mutations in DNA repair genes CtIP and MRE11 confer hypersensitivity to poly (ADP-ribose) polymerase inhibitors in myeloid malignancies
- (2013) T. J. Gaymes et al. HAEMATOLOGICA
- In Vitro and In Vivo Enhancement of Chemoradiation Using the Oral PARP Inhibitor ABT-888 in Colorectal Cancer Cells
- (2013) Joseph W. Shelton et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Replication stress links structural and numerical cancer chromosomal instability
- (2013) Rebecca A. Burrell et al. NATURE
- JMJD1C demethylates MDC1 to regulate the RNF8 and BRCA1–mediated chromatin response to DNA breaks
- (2013) Sugiko Watanabe et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Targeting homologous recombination and telomerase in Barrett’s adenocarcinoma: impact on telomere maintenance, genomic instability and tumor growth
- (2013) R Lu et al. ONCOGENE
- Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase Inhibition Is Synthetically Lethal in XRCC1 Deficient Ovarian Cancer Cells
- (2013) Rebeka Sultana et al. PLoS One
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- DNA Damage Sensing by the ATM and ATR Kinases
- (2013) A. Marechal et al. Cold Spring Harbor Perspectives in Biology
- Oxidation-Mediated DNA Cross-Linking Contributes to the Toxicity of 6-Thioguanine in Human Cells
- (2012) R. Brem et al. CANCER RESEARCH
- The PARP inhibitor ABT-888 synergizes irinotecan treatment of colon cancer cell lines
- (2012) David Davidson et al. INVESTIGATIONAL NEW DRUGS
- Enhancement of Synthetic Lethality via Combinations of ABT-888, a PARP Inhibitor, and Carboplatin In Vitro and In Vivo Using BRCA1 and BRCA2 Isogenic Models
- (2012) C. C. Clark et al. MOLECULAR CANCER THERAPEUTICS
- Loss of 53BP1 Causes PARP Inhibitor Resistance in Brca1 -Mutated Mouse Mammary Tumors
- (2012) Janneke E. Jaspers et al. Cancer Discovery
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Identification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell lines
- (2011) A Peasland et al. BRITISH JOURNAL OF CANCER
- DNA mismatch repair proficiency executing 5-fluorouracil cytotoxicity in colorectal cancer cells
- (2011) Moriya Iwaizumi et al. CANCER BIOLOGY & THERAPY
- MRE11 Deficiency Increases Sensitivity to Poly(ADP-ribose) Polymerase Inhibition in Microsatellite Unstable Colorectal Cancers
- (2011) E. Vilar et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Phosphorylation-regulated binding of Ctp1 to Nbs1 is critical for repair of DNA double-strand breaks
- (2011) Gerald E. Dodson et al. CELL CYCLE
- The Homologous Recombination Protein RAD51D Mediates the Processing of 6-Thioguanine Lesions Downstream of Mismatch Repair
- (2011) P. Rajesh et al. MOLECULAR CANCER RESEARCH
- Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR
- (2011) Philip M Reaper et al. Nature Chemical Biology
- A cell-based screen identifies ATR inhibitors with synthetic lethal properties for cancer-associated mutations
- (2011) Luis I Toledo et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Chromosome Segregation Errors as a Cause of DNA Damage and Structural Chromosome Aberrations
- (2011) A. Janssen et al. SCIENCE
- DNA Damage Activates a Spatially Distinct Late Cytoplasmic Cell-Cycle Checkpoint Network Controlled by MK2-Mediated RNA Stabilization
- (2010) H. Christian Reinhardt et al. MOLECULAR CELL
- The DNA Damage Response: Making It Safe to Play with Knives
- (2010) Alberto Ciccia et al. MOLECULAR CELL
- 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers
- (2010) Peter Bouwman et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- BRCA2 acts as a RAD51 loader to facilitate telomere replication and capping
- (2010) Sophie Badie et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- DNA damage and decisions: CtIP coordinates DNA repair and cell cycle checkpoints
- (2010) Zhongsheng You et al. TRENDS IN CELL BIOLOGY
- The DNA-damage response in human biology and disease
- (2009) Stephen P. Jackson et al. NATURE
- BRCA1 and its toolbox for the maintenance of genome integrity
- (2009) Michael S.Y. Huen et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Genome instability: a mechanistic view of its causes and consequences
- (2008) Andrés Aguilera et al. NATURE REVIEWS GENETICS
- An Oncogene-Induced DNA Damage Model for Cancer Development
- (2008) T. D. Halazonetis et al. SCIENCE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started